47
Views
28
CrossRef citations to date
0
Altmetric
Research Article

Significance of Anti-oxidized LDL Antibody and Monocyte-derived Microparticles in Anti-phospholipid Antibody Syndrome

, , , , &
Pages 125-131 | Received 03 Jul 2002, Accepted 14 Nov 2002, Published online: 07 Jul 2009

References

  • Murakami, T., Komiyama, Y, Masuda, M., Kido, H., Nomura, S., Fukuhara, S., et al. (1996) "Flow cytometric analysis of platelet activation markers CD62P and CD63 in patients with coronary artery disease", Eur. J. Clin. Investig. 26, 996–1003.
  • Miyazaki, Y., Nomura, S., Miyake, T., Kagawa, H., Kitada, C., Taniguchi, H., et al. (1996) "High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles", Blood 88, 3456–3464.
  • Weyrich, A.S., Elstad, M.R., McEver, RR, McIntyre, TM., Moore, K.L., Morrissey, J.H., et al. (1996) "Activated platelets signal chemokine synthesis by human monocytes", J. Clin. Investig. 97, 1525–1534.
  • Neumann, FL, Marx, N., Gawaz, M., Brand, K., Ott, I., Rokitta, C., et al. (1997) "Induction of cytokine expression in leukocytes by binding of thrombin stimulated platelets", Circulation 95, 2387–2394.
  • Laszik, Z., Jansen, P.J., Cummings, RD., Tedder, T.F., McEver, R.P. and Moore, K.L. (1996) "P-selectin glycoprotein ligand-1 is broadly expressed in cells of myeloid, lymphoid, and dendritic lineage and in some nonhematopoietic cells", Blood 88, 3010–3010.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.